{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T17:50:56Z","timestamp":1784397056162,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jneuroim.2024.578460","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T05:57:26Z","timestamp":1726725446000},"page":"578460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Characteristics of anti-contactin1 antibody positive autoimmune nodopathies combined with membranous nephropathy"],"prefix":"10.1016","volume":"396","author":[{"given":"Ying","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Lin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Lu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong-Cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Sheng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2024.578460_bb0005","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1388-2457(01)00469-2","article-title":"Terminal latency index and modified F ratio in distinction of chronic demyelinating neuropathies","volume":"112","author":"Attarian","year":"2001","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.jneuroim.2024.578460_bb0010","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0896-6273(01)00296-3","article-title":"Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve","volume":"30","author":"Boyle","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.jneuroim.2024.578460_bb0015","first-page":"7","article-title":"Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: clinical relevance of IgG isotype","author":"Cortese","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2024.578460_bb0020","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2215\/CJN.11761116","article-title":"Primary membranous nephropathy","volume":"12","author":"Couser","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jneuroim.2024.578460_bb0025","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1007\/s00415-020-10041-z","article-title":"Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera","volume":"267","author":"Delmont","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578460_bb0030","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/brain\/awab116","article-title":"Elucidating autoimmune nodopathies and the CIDP spectrum","volume":"144","author":"van Doorn","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2024.578460_bb0035","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/jnnp-2014-309916","article-title":"Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies","volume":"86","author":"Doppler","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2024.578460_bb0040","first-page":"7","article-title":"Contactin-1 autoimmunity: serologic, neurologic, and pathologic correlates","author":"Dubey","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2024.578460_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0281156","article-title":"Contactin-1 links autoimmune neuropathy and membranous glomerulonephritis","volume":"18","author":"Fehmi","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2024.578460_bb0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11910-023-01264-4","article-title":"Growing Spectrum of autoimmune Nodopathies","volume":"23","author":"Gupta","year":"2023","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.jneuroim.2024.578460_bb0055","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3389\/fneur.2018.00997","article-title":"Chronic inflammatory demyelinating polyneuropathy with concurrent membranous nephropathy: an anti-paranode and podocyte protein antibody study and literature survey","volume":"9","author":"Hashimoto","year":"2018","journal-title":"Front. Neurol."},{"issue":"100","key":"10.1016\/j.jneuroim.2024.578460_bb0060","first-page":"S1","article-title":"Clinical practice guideline for the Management of Glomerular Diseases","volume":"2021","author":"Kidney Disease: Improving Global Outcomes Glomerular Diseases Work G. KDIGO","year":"2021","journal-title":"Kidney Int."},{"key":"10.1016\/j.jneuroim.2024.578460_bb0065","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/jnnp-2016-314895","article-title":"Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies","volume":"88","author":"Koike","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2024.578460_bb0070","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.clinph.2020.01.013","article-title":"Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins","volume":"131","author":"Kouton","year":"2020","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.jneuroim.2024.578460_bb0075","doi-asserted-by":"crossref","first-page":"7907","DOI":"10.1074\/jbc.M113.528489","article-title":"Specific contactin N-glycans are implicated in neurofascin binding and autoimmune targeting in peripheral neuropathies","volume":"289","author":"Labasque","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2024.578460_bb0080","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.kint.2021.08.014","article-title":"Contactin-1 is a novel target antigen in membranous nephropathy associated with chronic inflammatory demyelinating polyneuropathy","volume":"100","author":"Le Quintrec","year":"2021","journal-title":"Kidney Int."},{"key":"10.1016\/j.jneuroim.2024.578460_bb0085","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1007\/s10072-021-05811-0","article-title":"Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database","volume":"43","author":"Liberatore","year":"2022","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2024.578460_bb0090","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/mus.20678","article-title":"Terminal latency index in neuropathy with antibodies against myelin-associated glycoproteins","volume":"35","author":"Lupu","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2024.578460_bb0095","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/WCO.0000000000001107","article-title":"Autoimmune nodopathies, an emerging diagnostic category","volume":"35","author":"Martin-Aguilar","year":"2022","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578460_bb0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jneuroim.2017.05.002","article-title":"Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies","volume":"309","author":"Mathey","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2024.578460_bb0105","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/jnnp-2011-301472","article-title":"Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP","volume":"83","author":"Mauermann","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2024.578460_bb0110","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/brain\/awv054","article-title":"Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia","volume":"138","author":"Miura","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2024.578460_bb0115","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jnnp-2011-301706","article-title":"Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy","volume":"83","author":"Nasu","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2024.578460_bb0120","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1017\/cjn.2020.46","article-title":"Chronic inflammatory demyelinating polyneuropathy and concurrent membranous nephropathy","volume":"47","author":"Nazarali","year":"2020","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2024.578460_bb0125","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.kint.2021.08.029","article-title":"Contactin-1-associated membranous nephropathy: complete immunologic and clinical remission with rituximab","volume":"100","author":"Plaisier","year":"2021","journal-title":"Kidney Int."},{"key":"10.1016\/j.jneuroim.2024.578460_bb0130","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.23794","article-title":"Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy","volume":"73","author":"Querol","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578460_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0169-328X(94)90372-7","article-title":"Identification and characterization of the human cell adhesion molecule contactin","volume":"21","author":"Reid","year":"1994","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.jneuroim.2024.578460_bb0140","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/CND.0000000000000395","article-title":"Rituximab responsive relapsing-remitting IgG4 Anticontactin 1 chronic inflammatory demyelinating Polyradiculoneuropathy associated with membranous nephropathy: a case description and brief review","volume":"23","author":"Remiche","year":"2022","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"10.1016\/j.jneuroim.2024.578460_bb0145","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1681\/ASN.2014111061","article-title":"Epitope spreading of autoantibody response to PLA2R associates with poor prognosis in membranous nephropathy","volume":"27","author":"Seitz-Polski","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jneuroim.2024.578460_bb0150","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1002\/mus.26392","article-title":"\u201cneuro-renal syndrome\u201d related to anti-contactin-1 antibodies","volume":"59","author":"Taieb","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2024.578460_bb0155","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.nmd.2022.01.006","article-title":"Autoantibody profile in a Malaysian cohort of chronic inflammatory demyelinating polyneuropathy","volume":"32","author":"Tan","year":"2022","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jneuroim.2024.578460_bb0160","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/acn3.51754","article-title":"CIDP\/autoimmune nodopathies with nephropathy: a case series study","volume":"10","author":"Tang","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578460_bb0165","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1111\/ene.14959","article-title":"European academy of neurology\/peripheral nerve society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision","volume":"28","author":"Van den Bergh","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578460_bb0170","article-title":"Case report: autoimmune nodopathy with concurrent serum and CSF IgG4 anti-neurofascin 155 antibodies","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578460_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.759187","article-title":"Characteristics of anti-Contactin1 antibody-associated autoimmune Nodopathies with concomitant membranous nephropathy","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Immunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572824001796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572824001796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T07:58:05Z","timestamp":1731484685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572824001796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":35,"alternative-id":["S0165572824001796"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2024.578460","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of anti-contactin1 antibody positive autoimmune nodopathies combined with membranous nephropathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2024.578460","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"578460"}}